The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,587.00
Bid: 1,586.00
Ask: 1,589.00
Change: -19.00 (-1.18%)
Spread: 3.00 (0.189%)
Open: 1,592.00
High: 1,601.00
Low: 1,587.00
Prev. Close: 1,606.00
SCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership with Wilden AG

27 Sep 2006 07:00

Screen Technology Group plc27 September 2006 For Immediate Release 27 September 2006 Screen Technology Group plc ("Screen Technology" or "the Company") Technical and financial partnership with Wilden AG Screen Technology Group plc ("Screen Technology" or "the Company" or "theGroup") the designer and manufacturer of revolutionary high-resolutionlarge-screen displays for high ambient light environments today announces anexciting new technical and financial partnership with Wilden AG. Highlights • Long-term supply arrangement for Wilden to supply injection moulded light-guides to Screen Technology.• Wilden will set up a production "cell" to produce light guides and operate Screen Technology's tile assembly machine to produce finished tiles.• Wilden will provide funds to acquire the first high-speed machine and provide long-term finance of the injection moulding tools.• Total investment by Wilden totalling over £1.2 million and over £500,000 by the beginning of 2007.• The partnership will accelerate Screen Technology's expansion of production resources.• Potential for Wilden to reproduce further production cells in locations around the world.• Wilden has the technical competence, financial resources and global reach to be a valuable partner for Screen Technology for the future. Peter Smyth, non-executive Chairman said "We are very excited by the partnership with Wilden AG, which will give us astrengthened platform for growth. Wilden, has the technical competence, theresources and the global reach to be a valuable partner and the investmentWilden is putting into the partnership will give us a greater ability to expandto meet expected market demands." Technical and financial partnership Screen Technology is pleased to announce that it has signed letters of intentwith Wilden AG ("Wilden") to enter into a partnership for the production ofinjection moulded light guides and the operation of the Company's first highspeed tile assembly machine. Wilden is a major producer of specialist high-quality high-technology injectionmouldings for the automotive, electronic and telecommunications and medicalindustries. Its customers include Daimler Chrysler, Astra Zeneca, Siemens,Sennheiser and Roche. Wilden has a broad international presence with facilitieslocated in North America, Western and Eastern Europe, and the Middle and FarEast. The agreement provides that Wilden will manufacture two new injection mouldingtools to produce light guides for use in the manufacture of ITrans tiles. Thecost of these tools will be spread over three years. Furthermore, Wilden has agreed to fund the acquisition of the first high speedtile assembly machine when it completes its factory acceptance testing, expectedto be in October of this year. Wilden will provide cash to meet the finalpayment due on the delivery of the machine with further payments amounting tothe full £1.1 million cost of the machine. Wilden's total contribution to thecost of moulding tools and the tile assembly machine is expected to amount toover £500,000 by the beginning of next year. In addition, Wilden will investitself in dedicated injection moulding machinery to produce the light guides ona 24/7 basis. Wilden will operate the tile assembly machine at its own premises on a sub-contract basis although the machine and all the intellectual property that goeswith the ITrans process will continue to belong to Screen Technology. The boardexpects this production "cell" making light guides and ITrans tiles at onelocation to be a model for more cells which may be located around the world. This partnership is a very exciting opportunity for Screen Technology. InWilden, we have found a partner with the technical competence and the resourcesand global reach to work with us through a period of rapid expansion.Furthermore the investment that Wilden is putting into this project in time andresources as well as significant cash commitment underlines the faith we bothhave in the success of ITrans. For more information please contact Screen Technology Group plc www.screentechnology.comThomas Jarman, CEO 01223 559600Simon Barton, Finance Director Buchanan Communications 020 74665000Isabel Podda Notes to Editors Screen Technology is the designer and manufacturer of revolutionaryhigh-resolution large-screen displays designed for high ambient lightenvironments. The high resolution and high definition of the Company's displays give ahigh-quality image suitable for advertising images and video as well as publicinformation displays. They are visible at short viewing distances as well asacross larger venues making them particularly suitable for large retail outlets,shopping malls, control rooms and transport concourses where customers might bewithin 10m of the display, a distance at which LED display technologies becomeunsuitable. The high brightness means that the displays are also easily visiblein the kind of high ambient light environments where conventional LCD or plasmatechnologies become unusable. Screen Technology's patent protected technology uses moulded optical fibre tilesto produce seamless large displays using standard production LCD panels. Thescaleable modular technology enables screens to be built in a wide variety ofshapes and of theoretically unlimited size. Screen Technology Group plc listed on AIM, a market operated by the London StockExchange, on 1 August 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th May 20243:09 pmRNSDirector/PDMR Shareholding
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company
9th Jan 20243:48 pmRNSDirector/PDMR Shareholding
9th Jan 202412:42 pmRNSHolding(s) in Company
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.